Skip to main content

Regenerative Medicine from lab to patient

Follow RegMed XB on LinkedIn
  • RegMed XB is a translational product development platform that brings together Dutch and Flemish public and private stakeholders to accelerate the development of innovative regenerative therapies.

    Business Development & Valorization

    Turn knowledge into value

    read more

    Research Excellence: Moonshots

    Push the boundaries of research excellence

    read more

    Infrastructure: RegMed XB's Pilot Factory

    A seamless pathway for innovators to accelerate, de-risk, and scale regenerative therapies

    read more

    Public-Private Entrepreneurship

    Building ecosystems through collaboration

    read more

    Seed Capital

    Secure early-stage funding

    read more
  • Phlox Therapeutics

    Phlox Therapeutics, is developing RNA-based therapies for genetic cardiomyopathies

    Phlox Therapeutics, is developing RNA-based therapies for genetic cardiomyopathies. Founded by Prof. Dr. Eva van Rooij and Prof. Dr. Yigal Pinto in 2022, the company has made significant progress with Dr. Margien Boels, PhD, as Chief Operating Officer. 

    read more
    Health-Holland Program 2025

    RegMed XB is awarded to be one of the selected programs by Health~Holland

    In October last year, RegMed XB applied for a 3-year Public-Private Partnership (PPS) subsidy program, called 'Regenerative Medicine Translational Synergy'. 

    read more
    News slider

    2024 in Review: RegMed XB Highlights

    As 2025 has started, we are sharing a look back with the RegMed XB Highlights 2024.

    read more
  • Moonshots (research excellence)

    Cardiovascular Moonshot

    Regeneration of the human heart

    read more

    Diabetes Moonshot

    A proof-of-concept therapy for Type 1 Diabetes

    read more

    Kidney Moonshot

    The first subunit of a bio-engineered kidney

    read more

    Osteoarthritis Moonshot

    The road to a bio-artificial joint

    read more
  • Pilot Factory (infrastructure)

    The RegMed XB Pilot Factory is one of the largest international infrastructures for regenerative medicine. It brings together all the expertise and infrastructure needed to bring regenerative medicine to the market.

    Pilot Factory

  • RegMed XB's Ecosystem

    Health Foundations

    The following Dutch health foundations are involved in defining research objectives and provide guidance in the research we conduct to ensure we maintain focus on the patient.

    read more

    Academic Partners

    RegMed XB works together with (inter)national top-rated academic institutions and collaborates specifically and exclusively with researchers who contribute specific expertise to the Moonshot initiatives.

    read more

    Industrial Partners

    Partnering with companies offers access to their expertise in designing scalable and feasible products. Currently, we have strong partnerships with the following entities.

    read more

    Governmental Partners

    RegMed XB receives support from national and local governments to de-risk promising concepts from academia to proof of concept or initial clinical trial stages.

    read more